Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.

PURPOSE:To compare the clinical benefit of robust optimized Intensity Modulated Proton Therapy (minimax IMPT) with current photon Intensity Modulated Radiation Therapy (IMRT) and PTV-based IMPT for head and neck cancer (HNC) patients. The clinical benefit is quantified in terms of both Normal Tissue...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Lisanne V van Dijk, Roel J H M Steenbakkers, Bennie ten Haken, Hans Paul van der Laan, Aart A van 't Veld, Johannes A Langendijk, Erik W Korevaar
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Online Access:	http://europepmc.org/articles/PMC4816406?pdf=render